Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma (Q57243254)

https://api.crossref.org/works/10.1038%2FONC.2015.440

Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Targeting mitochondria for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Epigenetics in cancer: targeting chromatin modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

A phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor with evidence of target modulation and antitumor activity, in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Targeting oxidative stress in embryonal rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Potentiation of neuroblastoma metastasis by loss of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

BH3-only proteins in apoptosis at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Deciphering the molecular events necessary for synergistic tumor cell apoptosis mediated by the histone deacetylase inhibitor vorinostat and the BH3 mimetic ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Loss of the BH3-only protein Bmf impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Guidelines for the welfare and use of animals in cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children with Relapsed Solid Tumor, Lymphoma or Leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.440

Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26616861

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Rhabdomyosarcoma: an overview

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26616861

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26616861